is a Heidelberg-based research consortium that aims to develop innovative proteomic and metabolomics tools to detect, model and predict cancer recurrence. Cancer recurrence is a major global health problem and the main determinant of cancer-related death. Yet, no accurate predictors exist that indicate disease progression in individual patients to prompt therapy in a timely manner.
SMART-CARE
Prof. Dr. Andreas von Deimling
University Hospital Heidelberg - Neuropathology
Prof. Dr. Sascha Dietrich
University Hospital Heidelberg - Clinic for Haematology, Oncology and Rheumatology
Prof. Dr. Thomas Grünewald
DKFZ - Division of Translational Pediatric Sarcoma Research (B410)
Prof. Dr. Rüdiger Hell
University Heidelberg - Centre for Organismal Studies
Prof. Dr. Thomas Höfer
DKFZ - Theoretical Systems Biology (B086)
Prof. Dr. Carsten Hopf
HS Mannheim - Center for Mass Spectrometry and Optical Spectroscopy
Dr. Wolfgang Huber
EMBL - Multi-omics and statistical computing
Prof. Dr. Ursula Klingmüller
DKFZ - Systems Biology of Signal Transduction (B200)
Prof. Dr. Petra Knaup-Gregori
University Hospital Heidelberg - Institute of Medical Informatics
Prof. Dr. Jeroen Krijgsveld
DKFZ & University Hospital Heidelberg - Proteomics of Stem Cells and Cancer (B230)
Prof. Dr. Carsten Müller-Tidow
University Hospital Heidelberg - Clinic for Haematology, Oncology and Rheumatology
Prof. Dr. Julio Saez-Rodriguez
University Hospital Heidelberg - Institute for Computational Biomedicine
Prof. Dr. Peter Schirmacher
University Hospital Heidelberg - Institute of Pathology
Prof. Dr. Hauke Winter
Thoraxklinik Heideberg - Thoracic surgery
SMART-CARE
Deutsches Krebsforschungszentrum
Universitätsklinikum Heidelberg
Abteilung Proteomics B230
Im Neuenheimer Feld 581
69120 Heidelberg
Germany